Clinical Trials on Acquired Immunodeficiency Syndrome

Total 34689 results

Centers for Disease Control and Prevention, China
Beijing Ditan Hospital; National Institutes for Food and Drug Control, China

Unknown

Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS

Acquired Immunodeficiency Syndrome

China
University of Washington
Centers for Disease Control and Prevention

Completed

Computer Assisted Rx Education for HIV-Positives: CARE+ (CARE+)

HIV Infections | Acquired Immunodeficiency Syndrome

United States
University of Washington
United States President's Emergency Plan for AIDS Relief; Mozambique Ministry...

Completed

Longitudinal Study of HAART, Social Networks, & Adherence

Acquired Immunodeficiency Syndrome

Mozambique
National Institute of Allergy and Infectious Diseases...

Completed

Analysis of Immune Responses to HIV Vaccines

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Center for Complementary and Integrative...

Completed

Immune Restoration by Lipoic Acid in AIDS

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Center for Complementary and Integrative...

Completed

The Use of Reiki for Patients With Advanced AIDS

HIV Infections | Acquired Immunodeficiency Syndrome

United States
Gilead Sciences

Recruiting

Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

HIV Infections | Acquired Immune Deficiency Syndrome (AIDS)

United States, Thailand, South Africa, Argentina, Panama, Zimbabwe, United Kingdom, Uganda
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study (LAIV)

Acquired Immune Deficiency Syndrome Virus

United Kingdom
Gilead Sciences

Completed

Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

HIV Infections | Acquired Immunodeficiency Syndrome

United States, Puerto Rico
National Institutes of Health Clinical Center (CC)

Completed

Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials

HIV Infections | Acquired Immunodeficiency Syndrome

United States
Gilead Sciences

Completed

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

HIV Infections | Acquired Immunodeficiency Syndrome

Canada, Switzerland, United States, France, Spain, Germany, Belgium, Austria, Italy, United Kingdom, Puerto Rico, Portugal
Gilead Sciences

Completed

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

HIV Infections | Acquired Immunodeficiency Syndrome

United States, Puerto Rico
Gilead Sciences

Completed

Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients

HIV Infections | Acquired Immunodeficiency Syndrome

United States, United Kingdom, France, Spain, Germany, Belgium, Puerto Rico, Canada, Italy, Austria, Australia, Portugal
University of California, San Francisco
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison

HIV Infections | Acquired Immunodeficiency Syndrome

United States
University of Washington
University of California, San Francisco; Kenya Medical Research Institute

Completed

Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV (SMS4PMTCT)

HIV Infections | Acquired Immunodeficiency Syndrome

Kenya
Boehringer Ingelheim

Completed

A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)

Acquired Immunodeficiency Syndrome

South Africa
Neurotune AG

Unknown

Dimiracetam in Painful Neuropathies Affecting AIDS Patients (DIPANAP)

Acquired Immunodeficiency Syndrome

Switzerland
International Partnership for Microbicides, Inc.

Completed

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

HIV Infections | Acquired Immunodeficiency Syndrome

Kenya, Malawi, Rwanda, South Africa, Tanzania
Kirby Institute

Completed

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. (ENCORE3)

Acquired Immunodeficiency Syndrome

United Kingdom
Federal University of São Paulo

Completed

Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients

HIV Infections | Acquired Immunodeficiency Syndrome

Brazil
National Cancer Institute (NCI)

Completed

A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers

HIV Infections | Acquired Immunodeficiency Syndrome

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs

HIV Infections | Acquired Immunodeficiency Syndrome

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk

Acquired Immunodeficiency Syndrome | HIV

United States
Gilead Sciences

Completed

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

HIV Infections | Acquired Immunodeficiency Syndrome | HIV-1

United States, Canada
National Bureau of Economic Research, Inc.
Emory University

Completed

A Commitment Device for Medication Adherence Among HIV Patients

Acquired Immunodeficiency Syndrome | HIV

United States
University of North Carolina, Chapel Hill

Completed

Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM)

Acquired Immunodeficiency Syndrome
International Partnership for Microbicides, Inc.

Completed

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

HIV Infections | Acquired Immunodeficiency Syndrome | Healthy

South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers

Acquired Immunodeficiency Syndrome | HIV Infection

United States
Merck Sharp & Dohme LLC

Withdrawn

MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)

HIV-1 | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1 | Human Immunodeficiency Virus 1
Merck Sharp & Dohme LLC

Recruiting

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection

United States, Mexico, Russian Federation, South Africa, Thailand
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)

Human Immunodeficiency Virus (HIV)

United States, Puerto Rico
RTI International
Centers for Disease Control and Prevention

Completed

Positive Health Check Evaluation Trial ((PHC))

Human Immunodeficiency Virus (HIV) Positive

United States
Johnson & Johnson Pte Ltd

Terminated

A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (RISE)

Human Immunodeficiency Virus Infections

India
GlaxoSmithKline

Completed

Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults

HIV Infections | Infection, Human Immunodeficiency Virus

United States, Canada
ViiV Healthcare

Completed

Phase 4 Study of Dolutegravir (DTG) in Russian Federation

HIV Infections | Infection, Human Immunodeficiency Virus

Russian Federation
University College Dublin
ViiV Healthcare; Mater Misericordiae University Hospital

Unknown

Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs (TAISTR)

Human Immunodeficiency Virus

Ireland
Beijing 302 Hospital

Completed

Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients

Human Immunodeficiency Virus | Immunodeficiency
St. Jude Children's Research Hospital

Completed

Medication Adherence in Human Immunodeficiency Virus (HIV)

Human Immunodeficiency Virus

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Smoking Cessation for HIV/AIDS Patients

Human Immunodeficiency Virus

United States
Abbott

Completed

Special Investigation of Kaletra in Pregnant Women

Human Immunodeficiency Virus

Japan
Abbott

Completed

Evaluation of Kaletra Therapy Over the Long-term

Human Immunodeficiency Virus

Germany
Seagen Inc.

Withdrawn

A Safety Study of Brentuximab Vedotin in Participants With HIV

Human Immunodeficiency Virus

United States
Imperial College London

Completed

Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIV (PACIFY)

Human Immunodeficiency Virus

United Kingdom
Janssen Vaccines & Prevention B.V.
Beth Israel Deaconess Medical Center; US Military HIV Research Program; Ragon...

Completed

A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

Human Immunodeficiency Virus

United States
University of Alabama at Birmingham

Completed

HIV Prevention in the Primary Care Setting

Human Immunodeficiency Virus

United States
AbbVie (prior sponsor, Abbott)
Veeda Clinical Research

Completed

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

Human Immunodeficiency Virus
Johns Hopkins University
National Institutes of Health (NIH)

Completed

Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

Human Immunodeficiency Virus

United States
Centre Hospitalier Universitaire de Saint Etienne

Completed

Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men (VIRECT)

Human Immunodeficiency Virus

France
Pfizer

Withdrawn

Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

Human Immunodeficiency Virus
AbbVie

Completed

Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)

Human Immunodeficiency Virus (HIV)

United States, Puerto Rico

Clinical Trials on Acquired Immunodeficiency Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations